Krystal Biotech, Inc.
KRYS
$256.33
$6.172.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.51% | 1.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.51% | 1.83% | |||
| Cost of Revenue | 54.63% | -40.50% | |||
| Gross Profit | 7.46% | 5.24% | |||
| SG&A Expenses | 10.30% | 6.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.36% | -0.54% | |||
| Operating Income | 7.00% | 5.26% | |||
| Income Before Tax | 6.60% | 2.55% | |||
| Income Tax Expenses | 99.14% | -471.93% | |||
| Earnings from Continuing Operations | -35.24% | 107.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.24% | 107.04% | |||
| EBIT | 7.00% | 5.26% | |||
| EBITDA | 7.57% | 5.19% | |||
| EPS Basic | -35.55% | 106.74% | |||
| Normalized Basic EPS | 6.08% | 2.39% | |||
| EPS Diluted | -35.94% | 106.20% | |||
| Normalized Diluted EPS | 5.12% | 2.26% | |||
| Average Basic Shares Outstanding | 0.48% | 0.15% | |||
| Average Diluted Shares Outstanding | 1.40% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||